Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis
Authors
Keywords
Breast cancer, Meta-analysis, Protein expression, Lymph nodes, Metastasis, Publication ethics, Prognosis, DNA transcription
Journal
PLoS One
Volume 12, Issue 4, Pages e0174843
Publisher
Public Library of Science (PLoS)
Online
2017-04-11
DOI
10.1371/journal.pone.0174843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
- (2016) Jingjing Liu et al. CANCER LETTERS
- Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis
- (2016) Yawen Guo et al. PLoS One
- GATA3 Expression in Advanced Breast Cancer: Prognostic Value and Organ-Specific Relapse
- (2015) Brandi C. McCleskey et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer
- (2015) Kyueng-Whan Min et al. VIRCHOWS ARCHIV
- Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer
- (2014) Mitsuchika Hosoda et al. BREAST CANCER RESEARCH AND TREATMENT
- GATA3mutations define a unique subtype of luminal-like breast cancer with improved survival
- (2014) Yi-Zhou Jiang et al. CANCER
- Transgenic mouse models in the study of reproduction: insights into GATA protein function
- (2014) Sergei G Tevosian REPRODUCTION
- Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer
- (2014) Yuichi Hisamatsu et al. Breast Cancer
- Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3–positive tumors
- (2013) H. Evin Gulbahce et al. HUMAN PATHOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Higher levels of GATA3 predict better survival in women with breast cancer
- (2010) Nam K. Yoon et al. HUMAN PATHOLOGY
- Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells
- (2009) Haihua Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GATA3 in development and cancer differentiation: Cells GATA have it!
- (2009) Jonathan Chou et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
- (2008) Hosein Kouros-Mehr et al. CANCER CELL
- GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value
- (2008) D. Voduc et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- GATA-3 and the regulation of the mammary luminal cell fate
- (2008) Hosein Kouros-Mehr et al. CURRENT OPINION IN CELL BIOLOGY
- The significance of GATA3 expression in breast cancer: a 10-year follow-up study
- (2008) Vincenzo Ciocca et al. HUMAN PATHOLOGY
- GATA-3 as a Marker of Hormone Response in Breast Cancer
- (2008) Sandy H. Fang et al. JOURNAL OF SURGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation